The African swine fever virus (ASFV) strain Malawi LIL20/1 open reading frame (ORF) j13L was expressed in vaccinia virus (VV) from a strong synthetic late promoter as either a complete ORF (vSJ1) or lacking codons 1-31 (vSJ2). Each recombinant VV produced a small plaque which rapidly reverted to a normal size upon passage. The yield of infectious virus from a single cycle infection with vSJ1 or vSJ2 was reduced 50-to 100-fold compared to wild-type (wt) and a revertant virus (vSJ5) in which the j13L ORF was removed and the VV thymidine kinase gene restored. PCR analysis of nine spontaneous large plaque revertant viruses, recovered after passage of vSJ1 in BSC-40 cells, showed that six had lost the j13L ORF and the co-inserted β-galactosidase gene. Three viruses retained the j13L and β-galactosidase
Introduction
Vaccinia virus (VV) is a large and complex virus of the poxvirus family which replicates in the cell cytoplasm and has a large dsDNA genome (Goebel et al., 1990 ; Moss, 1996) . VV replication produces two forms of structurally distinct, infectious virions termed intracellular mature virus (IMV) and extracellular enveloped virus (EEV). IMV contains a lipid membrane that was reported to be derived from the intermediate membrane compartment (Sodiek et al., 1993) . EEV is formed by wrapping IMV with two membranes derived from the trans-Golgi network (Schmelz et al., 1994) and movement of the resultant intracellular enveloped virus (IEV) to the cell surface on actin comets (Cudmore et al., 1995) or by an genes, but in each case the j13L protein was not expressed due to a different single base deletion near the 5h end of the j13L coding region which introduced a stop codon a short distance downstream. The formation of intracellular mature virus (IMV) and extracellular enveloped virus was reduced 50-to 75-fold in cells infected with vSJ1 compared to wt VV and revertant vSJ5. Electron microscopy showed aberrant IMV precursor structures in vSJ1-infected cells, and immunoelectron microscopy demonstrated that these structures contained j13L protein. These results indicate that expression of the j13L protein is toxic for VV replication due to interference with VV morphogenesis prior to IMV formation. independent mechanism. At the cell surface the outer IEV membrane fuses with the plasma membrane to form EEV. With some strains of virus the majority of EEV is retained on the cell surface as cell-associated enveloped virus (CEV) (Blasco & Moss, 1992) .
VV has been widely used as an expression vector and in the great majority of cases the expressed proteins have been correctly processed and transported and have not affected VV replication (Moss, 1991) .
Like VV, African swine fever virus (ASFV) is a large, complex virus with a linear dsDNA genome (Vin4 uela, 1985 ; Wilkinson, 1989 ; Costa, 1990 ; Ya! n4 ez et al., 1995) . The virus has a complex structure and contains a nucleoprotein core, icosahedral capsid and two membrane layers (Carrascosa et al., 1984) . ASFV assembly occurs in perinuclear factories and involves membranes originating from the endoplasmic reticulum (Brookes et al., 1996 ; Cobbold et al., 1996 ; Rouiller et al., 1998) . Structurally, ASFV is similar to the Iridoviridae, although its genome and mechanism of replication are more similar to poxviruses (for reviews see Vin4 uela, 1985 ; Costa, 1990) . Presently, ASFV is the only member of a separate virus genus .
More than 50 proteins are present in extracellular ASFV particles (Esteves et al., 1986 ) including a number of enzymes (Salas et al., 1981) . The genes encoding many ASF virion proteins have been identified (for references see Ya! n4 ez et al., 1995) , and include several proteins which contain predicted transmembrane domains (Camacho & Vin4 uela, 1991 ; Alcamı! et al., 1992 ; Rodriguez et al., 1994 ; Simo! n-Mate! o et al., 1995 ; Sun et al., 1995 Sun et al., , 1996 . Virion membrane proteins are likely to affect virus entry, morphogenesis and egress and to elicit an immune response in infected pigs.
One virion membrane protein, called j13L (Sun et al., 1995 ) or p54 (Rodriguez et al., 1994 , was predicted from nucleotide sequence data to be a 177 amino acid polypeptide in the ASFV strain Malawi LIL20\1 (Dixon et al., 1994) with a transmembrane domain (residues 32-52), followed by arrays of amino acid repeats which vary in number and sequence between different virus isolates (Rodriguez et al., 1994 ; Sun et al., 1995) . This protein can induce antibodies that neutralize ASFV infectivity by blocking virus attachment to cells (Go! mezPuertas et al., 1996) . To make greater amounts of this protein for biochemical characterization we have expressed the j13L gene downstream of a synthetic, strong, late VV promoter (Davison & Moss, 1990) as either a complete open reading frame (ORF) or, since it was unclear where the transcriptional start site for the gene was located, lacking the first 31 codons prior to the transmembrane domain. Surprisingly, the growth of each recombinant VV (rVV) was greatly diminished compared to wt and revertant viruses. Moreover, each rVV was unstable and rapidly generated viruses which grew normally but did not express the recombinant j13L protein.
Electron microscopy showed aberrant morphogenesis of VV in cells expressing the j13L protein. Possible reasons for this interference with VV replication are discussed.
Methods
Cells and viruses. VV strain Western Reserve (WR) and ASFV isolate Malawi LIL20\1 were used. VV was grown in CV-1, TK − 143, RK "$ or BSC-40 cells which were cultured in Dulbecco's modified Eagle's medium (DMEM) in 10 % foetal bovine serum (FBS). ASFV was grown in pig bone marrow cells as described (Brookes et al., 1996) .
Construction of rVVs.
A bacteriophage λ clone (LMw20) containing DNA from ASFV Malawi LIL20\1 (Dixon, 1988) was used as template for PCR amplification of fragments containing the j13L ORF. Oligonucleotide primers used were : (i) from the 3h end of the non-coding region of the j13L ORF including the stop codon, and (ii) from the 5h end of the coding strand either starting at the first ATG codon or from the second ATG codon 90 bp downstream. Each primer also included a 5h XbaI restriction enzyme site. The PCR fragments were digested with XbaI and cloned into the VV transfer vector pJM601 at a unique NheI site (Davison & Moss, 1990) . The resultant plasmids (pSJ1 and pSJ2 containing the complete or N-terminal-truncated j13L ORF, respectively) were transfected into VV-infected CV-1 cells and thymidine kinase (TK) negative rVVs were selected in the presence of 5-bromo-2-deoxyuridine (BrdU) and X-Gal on TK − 143 cells (Mackett et al., 1985) . rVVs were plaque purified three times and the presence of the expected insert confirmed by PCR using primers from the VV TK gene. A revertant virus with the TK gene of vSJ1 restored was generated by marker rescue with a plasmid containing the HindIII J fragment of VV strain Western Reserve (WR) as described (Weir et al., 1982) .
Immunoblotting. Cells were solubilized in Laemmli sample buffer (Laemmli, 1970) and proteins separated by SDS-PAGE on a 12 % gel. Proteins were transferred to nitrocellulose membranes which were incubated sequentially for 1 h at room temperature in PBS containing either 10 % FBS or 3 % (w\v) dried milk powder and 0n1% (v\v) Tween 20, and then in PBS and 0n1% (v\v) Tween 20 (washing buffer) containing a 1 : 1000 dilution of purified rabbit anti-j13L peptide immunoglobulin (Ig) (Sun et al., 1995) . Bound antibodies were detected using goat anti-rabbit IgG-horseradish peroxidase conjugate and enhanced chemiluminescence (ECL, Amersham).
Radioactive labelling of cells. Cells were incubated for 16 h with methionine-free DMEM prior to the addition of 250 µCi\ml [$&S]methionine (1175 Ci\mmol, New England Nuclear) in fresh methionine-free medium. At 24 h post-infection (p.i.) cells were washed with PBS and harvested in Laemmli sample buffer. Proteins were separated by SDS-PAGE (10 % gel) and detected by autoradiography.
Virus growth curve. BSC-40 cells were infected with either 0n1 or 10 p.f.u. per cell. Intracellular virus was harvested at the indicated times, released from cells by three cycles of freeze-thawing and sonication, and titrated on fresh monolayers of BSC-40 cells.
Measurement of IMV and EEV formation. RK "$ cells were infected at 10 p.f.u. per cell and incubated in MEM containing 2n5 % FBS for 2 h. The medium was then replaced with MEM containing 5 µCi\ml [$H]thymidine (6n7 Ci\mmol, New England Nuclear). At 24 h p.i. the IMV and EEV particles in the infected cells and supernatant were purified and quantified by CsCl density gradient centrifugation as described (Parkinson & Smith, 1994) . The infectivity of virus in the pooled CsCl fractions containing IMV (1n27 g\ml) or EEV (1n23 g\ml) was determined by plaque assay on BSC-40 cells.
Electron microscopy. BSC-40 cells were infected with VV strain WR, vSJ1 or vSJ2 at 1 p.f.u. per cell. Cells infected with WR were harvested at 4 or 6 h p.i., while cells infected with vSJ1 or vSJ2 were harvested 18 h p.i. when cells showed a similar degree of cytopathic effect (CPE). Cells were washed in Sorenson's phosphate (SP), fixed in 3 % paraformaldehyde in SP buffer and were processed to Lowicryl HM20 resin (Agar Scientific) by progressive lowering of the temperature to k30 mC (Hyatt, 1991) . Sections of approximately 90 nm were incubated with rabbit anti-j13L antibody at 1 : 100 dilution overnight at 4 mC and bound antibody detected with protein A-gold diluted 1 : 100 (Biocell International). The blocking buffer was PBS containing 5 % fish gelatin (Sigma), 100 mM glycine and 5 % goat serum and the diluent and wash buffer was this diluted 1 : 5 in PBS. Sections were post-fixed in 2n5% gluteraldehyde in PBS and examined in a Joel 1200ex transmission electron microscope. Alternatively, pellets were fixed in 2n5 % gluteraldehyde in 0n1 M cacodylate buffer and processed into Spurr's resin as described (Hyatt, 1991) .
Results

Construction of rVVs expressing the ASFV j13L protein
The complete j13L ORF, or one lacking the first 30 codons, was amplified from the cloned ASFV Malawi LIL20\1 genome by PCR, cloned into the VV transfer vector pMJ601 and sequenced. Clones were identified which had either the correct full-length j13L sequence, or which started at the first (pSJ1) or second ATG codon (pSJ2) and had different single base deletions within the C-terminal stop codon. pSJ1 and pSJ2 thus contained ORFs which read through into the vector sequence and contained an extra 19 amino acids at the C terminus ( Fig.  1 a) . All three of these plasmids were used to select rVVs by screening for expression of β-galactosidase, but recombinants were obtained only with plasmids described above which contained mutations at the C terminus of the j13L ORF and in these cases the plaques were very small compared to wild-type (wt ; see below). This suggested that the high level expression of normal or mutated j13L protein was toxic for VV. In addition, the mutations in the j13L stop codon prior to expression in VV suggested that either there were mutations within the oligonucleotide used for PCR or that the wild-type j13L protein might not have been well tolerated in bacteria.
To examine expression of the j13L protein, BSC-40 cells were infected with vSJ1, vSJ2 or wt VV, and as a control pig macrophages, prepared as described previously (Sun et al., 1995) , were infected with ASFV Malawi LIL20\1. Immunoblotting with purified Ig against a C-terminal peptide from the j13L protein (Sun et al., 1995) identified proteins of 25, 27 and 23 kDa in cells infected with ASFV, vSJ1 and vSJ2, respectively, but not in wt VV-infected cells (Fig. 1 b) . This was as expected since vSJ1 and vSJ2 have an extra 19 amino acids at the C terminus and vSJ2 contains a j13L ORF starting at the second ATG codon. Higher molecular mass proteins were recognized in vSJ1-and vSJ2-infected cells but not in ASFVinfected cells. These proteins might represent homodimers or other complexes and be specific for VV-infected cells because of their C-terminal extensions, different levels of expression or interaction with VV proteins. Comparison of total [$&S]methionine-labelled cell proteins harvested at various times p.i. showed that the pattern of early and late VV protein synthesis in cells infected with vSJ1 and vSJ2 was the same as in wt VV (data not shown).
Growth characteristics of rVVs expressing the j13L ORF
During the isolation of vSJ1 and vSJ2 it was noticed that each virus formed small plaques compared to wt and this was compared directly by plating each virus onto BSC-40 cells in parallel (Fig. 2) . Recombinants with or without the first 30 codons of the j13L ORF each formed plaques which were smaller than those of wt (Fig. 2) . However, this small plaque phenotype was unstable since, when virus was harvested from cells 49 h p.i. with vSJ1 and replated onto fresh BSC-40 monolayers, a mixture of small and large plaques was obtained (Fig. 2) . Similarly, large plaques rapidly arose after passage of vSJ2 (Fig. 2) . To confirm that this small plaque phenotype was due to the presence of the j13L ORF, a revertant virus was constructed from vSJ1 in which the j13L ORF and β-galactosidase marker gene were removed and the TK gene restored (see Methods). This revertant virus (vSJ5) produced plaques the same size as wt (Fig. 2) , indicating it was the j13L ORF, or the β-galactosidase gene, that was responsible for the small plaque phenotype.
The growth characteristics of vSJ1, vSJ2, vSJ5 and wt were more closely examined during growth curves after low (0n1 p.f.u. per cell) or high (10 p.f.u. per cell) m.o.i. of BSC-40 BBHB S. C. Jacobs and others S. C. Jacobs and others cells (Fig. 3) . When cells were infected at low m.o.i. (Fig. 3 a) , wt and revertant vSJ5 reached near maximal titres by 24 h p.i. and there was little subsequent change. In contrast, vSJ1 and vSJ2 had titres much lower than wt at 24 and 36 h p.i., but these titres continued to increase so that by 48 h p.i. they approached that of wt. This probably reflects the appearance and spread of large plaque mutants which eventually outgrew the small plaque parental virus and replicated to titres comparable with wt. After high m.o.i. infection the situation was different (Fig.  3 b) . Under these conditions infection with vSJ1 and vSJ2 resulted in every cell expressing j13L protein so that replication and spread of any large plaque viruses would be restricted. Notably, vSJ1 reached near maximum titre by 24 h p.i. and only increased slightly in the next 24 h, and at both 24 and 48 h p.i. the vSJ1 titre was more than 50-fold lower than wt or vSJ5 (Fig. 3 b) .
Analysis of revertant large plaque viruses
These data suggested that expression of the j13L protein restricts VV growth and causes a small plaque phenotype. The nature of the spontaneous large plaque isolates that rapidly appeared during passage of vSJ1 and vSJ2 (Fig. 2) was therefore analysed in more detail. Nine large plaque isolates (three from vSJ2 and six from vSJ1) were plaque purified and examined for expression of j13L and β-galactosidase proteins and their genomic structure at the TK locus was investigated. In the presence of X-Gal only three of these viruses formed blue plaques, indicating expression of β-galactosidase (Table 1) . The expression of the j13L protein was analysed by immunofluorescence, using purified Ig raised against the C-terminal peptide of the j13L protein, and showed that none of the nine plaques express the C-terminal part of the j13L protein. In contrast, both vSJ1-and vSJ2-infected cells were strongly recognized by the anti-j13L antibody (Table 1) and showed cytoplasmic staining. The fact that all the large plaque isolates had lost expression of the j13L protein but three retained expression of β-galactosidase confirmed it was j13L rather than β-galactosidase that was responsible for the small plaque phenotype.
The genomic structure of the spontaneous large plaque isolates was examined by PCR using primers from the VV TK gene. This produced 4 kb fragments from vSJ1 and vSJ2 and each large plaque isolate which expressed β-galactosidase (Table 1) . In contrast, a fragment of only about 700 bp was amplified from the genomes of five other large plaque isolates and a 1n5 kb fragment from isolate 612 ( Table 1) . As these are only about 250 or 1050 bp larger than the fragment amplified from the genome of wt VV (440 bp) this indicated that most of both the j13L ORF and the β-galactosidase gene had been deleted from these viruses. Table 1 . Summary of the characteristics of the different VVs β-Galactosidase expression was determined by blue plaque formation in the presence of X-Gal. j13L expression was determined by immunofluorescence using Ig raised against the C-terminal region of the j13L protein. The PCR fragments were amplified from each virus using oligonucleotide primers from within the VV TK gene. Virus isolates marked with an asterisk were derived by passage of vSJ1 and others were derived from vSJ2.
BBHC
Virus name
Plaque size β-Galactosidase expression j13L protein expression PCR fragment size (kb) 
Sequence analysis of large plaque isolates
PCR fragments were amplified from the genomes of the three viruses (604, 2a and 608) which retained the full size insert and expressed β-galactosidase, and were cloned into pGEM-T. The sequence of the j13L insert was then determined using j13L-specific primers. Sequences were determined from clones derived from several different PCRs to minimize the possibility that any changes were due to mutations introduced during PCR. This analysis showed that a single nucleotide deletion had occurred near the 5h end of the j13L ORF in all three viruses, which resulted in termination of translation at an in-frame stop codon a short distance downstream (Fig. 4) . For virus isolate 604, derived from vSJ1, the resulting ORF encoded the authentic first 17 residues of the j13L protein followed by 23 residues translated from a different reading frame (Fig. 4) . Viruses 608 and 2a, derived from vSJ2, had single base deletions 9 or 27 nucleotides downstream from codon 31. The resultant ORFs encoded peptides containing 10 residues of which the first 3 or 9 were authentic (Fig. 4) . This analysis strongly suggested that it was expression of the j13L protein rather than the j13L DNA sequence which caused growth inhibition of VV and the small plaque phenotype.
IMV and EEV formation by rVV vSJ1 expressing j13L
The reduced virus titres obtained from cells infected at high m.o.i. with vSJ1 compared to wt (Fig. 3 b) suggested that the small plaque phenotype might be due to reduced virus production rather than diminished cell-to-cell spread. The production of IMV and EEV was therefore analysed in more detail by labelling vSJ1-infected cells with [$H]thymidine and purifying IMV and EEV by CsCl density gradient centrifugation. This analysis showed that similar levels of IMV and EEV were formed by wt and revertant vSJ5, but these were BBHD S. C. Jacobs and others S. C. Jacobs and others (Parkinson & Smith, 1994) . Gradient fractions were assayed for radioactivity by scintillation counting, for density by refractometry and for virus infectivity by plaque assay on BSC-40 cells. The arrows indicate the positions of the IMV (1n27 g/ml) and EEV or CEV (1n23 g/ml) particles.
reduced 60-to 80-fold for vSJ1 IMV and EEV (Fig. 5) . Infectivity titrations of virus recovered from the IMV and EEV peaks showed a similar reduction in IMV (75-fold) and EEV (40-to 50-fold) for vSJ1. Thus the reduced production of infectious virus by vSJ1 was due to reduced particle formation rather than a reduced specific infectivity of virions.
j13L is incorporated into abnormal forms of VV
To examine the effect of j13L expression on VV morphogenesis, BSC-40 cells were infected with VV WR or recombinants vSJ1 or vSJ2 and examined by electron microscopy (see Methods). In wt VV-infected cells the typical crescents and immature virions (IVs) were clearly visible (Fig.  6 a) . In contrast, in vSJ1-and vSJ2-infected cells there were numerous, aberrant IVs that contained incorrectly formed cores and membrane irregularities (Fig. 6 b, c) . To determine if these structures contained the j13L protein, Lowicryl thin sections were labelled with antibody to j13L (see Methods) and this revealed many gold particles associated predominantly with membrane elements of the virus factories and partially formed virions (Fig. 7) . Only a very low background labelling was observed on wt VV-infected cells (data not shown). This demonstrated that in cells infected with vSJ1 and vSJ2 the j13L protein was predominantly associated with membranes around virus factories and partially formed virions.
Discussion
The ASFV envelope protein j13L is shown here to be toxic for VV replication. Several independent observations support this conclusion. First, we were unable to isolate an rVV expressing the wt j13L ORF under conditions in which it was possible to obtain rVVs expressing mutated versions of the j13L protein which had a 19 amino acid extension at the C terminus with or without the N-terminal 31 amino acids. Previously, the expression of j13L by an rVV using the 7.5K promoter had been reported (Sun et al., 1995) , but in view of the present observations, the j13L gene in that virus was sequenced and also found to have a mutation causing a Cterminal extension. Second, the recombinant viruses which express the mutated j13L proteins produced very small plaques compared to wt and revertant viruses and produced 50-to 80-fold less infectious virus. Third, the expression of even the mutant j13L proteins was strongly selected against, since a single passage of viruses vSJ1 or vSJ2 yielded variant viruses which produced a large plaque and which either had lost the majority of the j13L gene, or had mutations near the 5h end which caused termination of the ORF near the N terminus. Fourth, electron microscopy showed that cells infected with vSJ1 or vSJ2 produced immature virions with aberrant morphology and which were shown by immunogold labelling to contain the j13L protein. Fifth, biochemical measurements showed the IMV and EEV particle production from these cells was reduced 50-to 80-fold.
How does the j13L protein inhibit VV replication ? Analysis of the replication of vSJ1 showed that early and late virus protein synthesis is normal (data not shown) but the assembly of virions was inhibited (Figs 5-7) . The components for new virus particles are evidently synthesized but their assembly into IMV particles, and consequently EEV, are inhibited by the j13L protein. Electron micrographs showed the accumulation of aberrant precursors of IMV consistent with the biochemical and infectivity measurements showing reduced IMV formation.
Assembly of VV begins with the appearance of crescents which were proposed to be synthesized de novo (for review see Dales & Pogo, 1981) , but which more recently were reported to be formed by modification of a cisternae derived from the intermediate compartment between the endoplasmic reticulum and the Golgi complex (Sodiek et al., 1993) . The crescent develops into a spherical IV which then matures into IMV. ASFV envelope protein j13L is toxic for VV ASFV envelope protein j13L is toxic for VV Since the j13L protein prevents correct IMV formation, it inhibits VV assembly at an early stage. The j13L protein contains a predicted transmembrane domain and is incorporated into the ASFV particles from where it can be released by 1 % NP40 or 1 % NOG, confirming it is membraneassociated (Rodriguez et al., 1994 ; Sun et al., 1995) . In ASFVinfected cells j13L (p54) is located in a distinct cytoplasmic region close to the cell nucleus that probably represents the endoplasmic reticulum\intermediate compartment\Golgi complex and overlaps virus factories, but j13L is not present at the plasma membrane (Rodriguez et al., 1994 ; Brookes et al., 1998) . The inner membrane of ASFV is derived from the endoplasmic reticulum which is modified by incorporation of virus proteins (Cobbold et al., 1996 ; Rouiller et al., 1998) . The presence of the j13L protein in the endoplasmic reticulum\intermediate compartment\Golgi complex membranes might be toxic to VV morphogenesis by interfering with the normal transport of proteins through these compartments, modifying these compartments so that they cannot be used normally for VV morphogenesis, or preventing VV protein-protein interactions. The fact that a membrane protein of one cytoplasmic DNA virus, ASFV, can interfere with the morphogenesis of another cytoplasmic DNA virus, VV, is interesting and although these viruses have quite different virion structures, may suggest that there are common elements in the early stages of morphogenesis of these viruses.
Several proteins involved in the early stages of VV assembly have been defined. VVs with temperature-sensitive (ts) lesions in the F10 protein kinase (Traktman et al., 1995 ; Wang & Shuman, 1995) or in which the A17L gene is repressed by the E. coli lac repressor undergo arrest before the formation of virus crescents (Rodrı! guez et al., 1995) . VV ts mutants with lesions in the I7 gene arrest between the IV and IMV forms and do not proteolytically process the major core proteins, p4a, p4b and 28 kDa (Erricsson et al., 1995) . The drug rifampicin reversibly blocks VV morphogenesis at an early stage (Moss et al., 1969) , and mutations in the D13 gene confer resistance to this inhibition (Tartaglia & Paoletti, 1985 ; Baldick & Moss, 1987) . The rVV expressing j13L may be useful in further defining the steps involved in VV assembly since the block in assembly in cells expressing j13L may be at a different step to that affected by currently described mutations.
VV recombinants have been widely used to express a broad range of recombinant proteins including many virus membrane proteins (Mackett & Smith, 1986 ; Moss, 1991) but there have been only a few reports of foreign proteins inhibiting VV replication. For membrane proteins this is probably because these proteins are usually either transported to the cell surface or are secreted and thus do not interfere with the intracellular assembly of IMV. In summary, we demonstrate that expression of the ASFV envelope protein j13L is toxic for VV replication and prevents the formation of IMV particles. The j13L protein might be toxic by accumulating in the same intracellular compartment used for VV morphogenesis and represents an interesting molecule for further studies on VV and ASFV morphogenesis.
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